Abstract
Mortality from stroke has been declining in New Zealand since 1950 and at an accelerating rate since the early 1970s. Hypertension is the single most important risk factor for stroke. The temporal association between the recent decline in mortality and an increase in the proportion of patients with hypertension detected and treated led to the assumption of a cause and effect relation. Data from studies of the prevalence of blood pressure carried out in the community and from therapeutic trials of the treatment of hypertension were used to estimate the proportion of the decline in mortality from stroke that could be accounted for by increased treatment of hypertension during 1973-82 in New Zealand. Treatment of hypertension was estimated to account for roughly 10% of the observed reduction in deaths from stroke. Greater understanding of the reasons for the decline in mortality from stroke is required.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bonita R., Beaglehole R., North J. D. Event, incidence and case fatality rates of cerebrovascular disease in Auckland, New Zealand. Am J Epidemiol. 1984 Aug;120(2):236–243. doi: 10.1093/oxfordjournals.aje.a113885. [DOI] [PubMed] [Google Scholar]
- Christmas B. W. Blood pressure levels of an urban adult New Zealand population: Napier 1973. N Z Med J. 1977 Oct 26;86(598):369–374. [PubMed] [Google Scholar]
- Dobson A. J., Gibberd R. W., Wheeler D. J., Leeder S. R. Age-specific trends in mortality from ischemic heart disease and cerebrovascular disease in Australia. Am J Epidemiol. 1981 Apr;113(4):404–412. doi: 10.1093/oxfordjournals.aje.a113108. [DOI] [PubMed] [Google Scholar]
- Haberman S., Capildeo R., Rose F. C. Diverging trends in cerebrovascular disease and ischaemic heart disease mortality. Stroke. 1982 Sep-Oct;13(5):582–589. doi: 10.1161/01.str.13.5.582. [DOI] [PubMed] [Google Scholar]
- Hay D. R., Foster F. H. Intercensal trends in cigarette smoking in New Zealand 1: age, sex and ethnic status. N Z Med J. 1984 May 9;97(755):283–285. [PubMed] [Google Scholar]
- Jackson R. T., Beaglehole R., Stewart A. W. Blood pressure levels and the treatment of hypertension in Auckland, 1982. N Z Med J. 1983 Oct 12;96(741):751–754. [PubMed] [Google Scholar]
- Kannel W. B., Wolf P. A., Verter J., McNamara P. M. Epidemiologic assessment of the role of blood pressure in stroke. The Framingham study. JAMA. 1970 Oct 12;214(2):301–310. [PubMed] [Google Scholar]
- Levy R. I., Moskowitz J. Cardiovascular research: decades of progress, a decade of promise. Science. 1982 Jul 9;217(4555):121–129. doi: 10.1126/science.7046047. [DOI] [PubMed] [Google Scholar]
- Simpson F. O., Waal-Manning H. J., Bolli P., Spears G. F. The Milton Survey. 2. Blood pressure and heart rate. N Z Med J. 1978 Jul 12;88(615):1–4. [PubMed] [Google Scholar]
- Soltero I., Cooper R. Improved hypertension control and decline in cardiovascular mortality. Compr Ther. 1980 Mar;6(3):60–64. [PubMed] [Google Scholar]
- Soltero I., Liu K., Cooper R., Stamler J., Garside D. Trends in mortality from cerebrovascular diseases in the United States, 1960 to 1975. Stroke. 1978 Nov-Dec;9(6):549–558. doi: 10.1161/01.str.9.6.549. [DOI] [PubMed] [Google Scholar]
- Warlow C. Carotid endarterectomy: does it work? Stroke. 1984 Nov-Dec;15(6):1068–1076. doi: 10.1161/01.str.15.6.1068. [DOI] [PubMed] [Google Scholar]
- Whisnant J. P. The decline of stroke. Stroke. 1984 Jan-Feb;15(1):160–168. doi: 10.1161/01.str.15.1.160. [DOI] [PubMed] [Google Scholar]
- Wilhelmsen L., Svärdsudd K., Korsan-Bengtsen K., Larsson B., Welin L., Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med. 1984 Aug 23;311(8):501–505. doi: 10.1056/NEJM198408233110804. [DOI] [PubMed] [Google Scholar]